DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Green tea consumption increases number of 'regulatory T cells', prevents autoimmune disease

One of the beneficial compounds found in green tea has a powerful ability to increase the number of "regulatory T cells" that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University.

3 Jun 2011

LabCorp extends cash tender offer for all shares of Orchid common stock

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 6:00 p.m., New York City time, on June 15, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc.

3 Jun 2011

Johns Hopkins researchers solve mystery of Warburg effect

It’s long been known that cancer cells eat a lot of sugar to stay alive. In fact, where normal, noncancerous cells generate energy from using some sugar and a lot of oxygen, cancerous cells use virtually no oxygen and a lot of sugar. Many genes have been implicated in this process and now, reporting in the May 27 issue of Cell, researchers at the Johns Hopkins University School of Medicine have discovered that this so-called Warburg effect is controlled.

2 Jun 2011

Biowave II UV-Vis spectrophotometers for low volume DNA measurements: Special offer

A great solution for measuring DNA in low volume samples, Biowave II / II+ UV-Vis spectrophotometers from Biochrom now come with 500 70µl disposable cuvettes and a 100 µl pipette free of charge. To take advantage of this offer, please contact your local distributor or send an email to [email protected]

From Biochrom Ltd. 2 Jun 2011

OncoSec Medical to present results of ElectroImmunotherapy clinical trial in melanoma at ASCO 2011

OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that one of its clinical trial advisers will present results from an ElectroImmunotherapy clinical trial for melanoma at the 2011 American Society of Clinical Oncology Annual Meeting to be held June 4-8 at McCormick Place, Chicago, IL.

2 Jun 2011

PCF funds 14 new Creativity Awards for advanced prostate cancer research

The Prostate Cancer Foundation today announced that it has funded 14 new Creativity Awards for advanced prostate cancer research. These two-year awards are designed to support innovative research ideas that have the potential to achieve breakthroughs for improved prostate cancer diagnosis and treatment.

2 Jun 2011

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.

1 Jun 2011

Elsevier to organise third Current Opinion conference in structural biology, DNA repair

Elsevier, the leading provider of scientific, technical and medical information products and services, is organising the third Current Opinion conference, the Current Opinion in Structural Biology & DNA Repair.

1 Jun 2011

Scientists find no link between XMRV retrovirus and human disease

Delineation of the origin of the retrovirus known as XMRV from the genomes of laboratory mice indicates that the virus is unlikely to be responsible for either prostate cancer or chronic fatigue syndrome in humans, as has been widely published.

1 Jun 2011

New genetic test can predict clinical outcomes in glioblastoma patients

New research proves that a change in a particular gene can identify which patients with a specific kind of brain cancer will respond better to treatment. Testing for the gene can distinguish patients with a more- or less-aggressive form of glioblastoma, the most common and an often-fatal type of primary brain cancer, and help guide therapy, the researchers say.

1 Jun 2011

Almac's main research projects on ovarian, breast cancer to be presented at ASCO 2011

Two of Almac's main research projects have been selected for presentation at the 2011 ASCO meeting. Both of these studies are based on Almac's approach of profiling large clinical datasets and analysing the data for molecular subgroups that can aid in improved diagnosis of cancer by identifying molecular subtypes and by identifying molecular subgroups which are of clinical and therapeutic relevance.

31 May 2011

Study: E-waste linked to adverse effects on human health

In addition to its damaging effect on the environment and its illegal smuggling into developing countries, researchers have now linked e-waste to adverse effects on human health, such as inflammation and oxidative stress - precursors to cardiovascular disease, DNA damage and possibly cancer.

31 May 2011

Mouse Phylogeny Viewer

Laboratory research has always been limited in terms of what conclusions scientists can safely extrapolate from animal experiments to the human population as a whole. Many promising findings in mice have not held up under further experimentation, in part because laboratory animals, bred from a limited genetic foundation, don't provide a good representation of how genetic diversity manifests in the broader human population.

30 May 2011

Pre-implantation genetic diagnosis can avoid mother to child transmission of mtDNA disorders

Dutch researchers have developed a test which predicts which mothers at risk of passing on mitochondrial genetic disease to their children are likely to have a healthy baby.

30 May 2011

JRC report shows how molecular technologies can help combat illegal fishing, support traceability

Low-cost catfish fillets sold as expensive sole fillets or cod caught in the North Sea but declared as originating from the Baltic Sea are both examples of types of fraud in the fisheries sector. A European Commission report published today shows how molecular technologies - based on genetics, genomics, chemistry and forensics - can provide clear answers to questions such as "what species does this fish product come from….where was this fish caught….is it wild or farmed?".

30 May 2011

New insights into pathogenesis and treatment of hereditary breast, ovarian cancer

5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Ärzteblatt International, Alfons Meindl of the Klinikum rechts der Isar and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes.

30 May 2011

IT-IS Life Sciences, Roche sign exclusive distribution agreement for new LightCycler Nano Instrument

Roche Applied Science has signed a worldwide exclusive OEM agreement with IT-IS Life Sciences Ltd for the distribution of the new LightCycler Nano Instrument, which will complete the company´s portfolio for the low throughput real-time PCR systems market.

30 May 2011

Possible defense for community-acquired pneumonia among the elderly

Community-acquired pneumonia is the leading cause of infectious death among the elderly. Newly published research from The University of Texas Health Science Center San Antonio suggests why older people are vulnerable and offers a possible defense.

27 May 2011

DNA-based traceability system tracks beef

Starting today, 11,000 U.S. restaurants that serve Braveheart Black Angus Beef will be able to assure diners a guarantee of quality about their premium Angus beef through DNA TraceBack®, the nation's first-of-its-kind assurance of quality and commitment.

27 May 2011

Lactate shuttle also exists in human tumors

Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow-and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize.

27 May 2011

DNA News and Research

Further Reading

Green tea consumption increases number of 'regulatory T cells', prevents autoimmune disease

LabCorp extends cash tender offer for all shares of Orchid common stock

Johns Hopkins researchers solve mystery of Warburg effect

Biowave II UV-Vis spectrophotometers for low volume DNA measurements: Special offer

OncoSec Medical to present results of ElectroImmunotherapy clinical trial in melanoma at ASCO 2011

PCF funds 14 new Creativity Awards for advanced prostate cancer research

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Elsevier to organise third Current Opinion conference in structural biology, DNA repair

Scientists find no link between XMRV retrovirus and human disease

New genetic test can predict clinical outcomes in glioblastoma patients

Almac's main research projects on ovarian, breast cancer to be presented at ASCO 2011

Study: E-waste linked to adverse effects on human health

Mouse Phylogeny Viewer

Pre-implantation genetic diagnosis can avoid mother to child transmission of mtDNA disorders

JRC report shows how molecular technologies can help combat illegal fishing, support traceability

New insights into pathogenesis and treatment of hereditary breast, ovarian cancer

IT-IS Life Sciences, Roche sign exclusive distribution agreement for new LightCycler Nano Instrument

Possible defense for community-acquired pneumonia among the elderly

DNA-based traceability system tracks beef

Lactate shuttle also exists in human tumors

Understanding the DNA Damage Response in Innate Immunity eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo